BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 33711555)

  • 1. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
    Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
    Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Acyl-CoA synthetase 5 (ACSL5) deficiency potentiates postprandial GLP-1 & PYY secretion, reduces food intake, and protects against diet-induced obesity.
    Griffin JD; Zhu Y; Reeves A; Buhman KK; Greenberg AS
    Mol Metab; 2024 May; 83():101918. PubMed ID: 38499083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-arginine promotes gut hormone release and reduces food intake in rodents.
    Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
    Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Enteroendocrine System for Treatment of Obesity.
    Miedzybrodzka EL; Gribble FM; Reimann F
    Handb Exp Pharmacol; 2022; 274():487-513. PubMed ID: 35419620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
    Akindehin S; Liskiewicz A; Liskiewicz D; Bernecker M; Garcia-Caceres C; Drucker DJ; Finan B; Grandl G; Gutgesell R; Hofmann SM; Khalil A; Liu X; Cota P; Bakhti M; Czarnecki O; Bastidas-Ponce A; Lickert H; Kang L; Maity G; Novikoff A; Parlee S; Pathak E; Schriever SC; Sterr M; Ussar S; Zhang Q; DiMarchi R; Tschöp MH; Pfluger PT; Douros JD; Müller TD
    Mol Metab; 2024 May; 83():101915. PubMed ID: 38492844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.
    Billing LJ; Smith CA; Larraufie P; Goldspink DA; Galvin S; Kay RG; Howe JD; Walker R; Pruna M; Glass L; Pais R; Gribble FM; Reimann F
    Mol Metab; 2018 Oct; 16():65-75. PubMed ID: 30104166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
    Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
    Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.
    Psichas A; Sleeth ML; Murphy KG; Brooks L; Bewick GA; Hanyaloglu AC; Ghatei MA; Bloom SR; Frost G
    Int J Obes (Lond); 2015 Mar; 39(3):424-9. PubMed ID: 25109781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut hormones and appetite regulation.
    Hong SH; Choi KM
    Curr Opin Endocrinol Diabetes Obes; 2024 Jun; 31(3):115-121. PubMed ID: 38511400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
    Kuhre RE; Wewer Albrechtsen NJ; Larsen O; Jepsen SL; Balk-Møller E; Andersen DB; Deacon CF; Schoonjans K; Reimann F; Gribble FM; Albrechtsen R; Hartmann B; Rosenkilde MM; Holst JJ
    Mol Metab; 2018 May; 11():84-95. PubMed ID: 29656109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of TOTUM-63, a fibre and polyphenol rich plant-based composition, on gut and pancreatic hormone secretion in diet-induced obese mice.
    Chavanelle V; Chanon S; Pinteur C; Loizon E; Vial G; Otero YF; Le Joubioux F; Maugard T; Peltier SL; Sirvent P; Morio B
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1797-1807. PubMed ID: 35618560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents.
    Alamshah A; Spreckley E; Norton M; Kinsey-Jones JS; Amin A; Ramgulam A; Cao Y; Johnson R; Saleh K; Akalestou E; Malik Z; Gonzalez-Abuin N; Jomard A; Amarsi R; Moolla A; Sargent PR; Gray GW; Bloom SR; Murphy KG
    Int J Obes (Lond); 2017 Nov; 41(11):1693-1701. PubMed ID: 28792489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
    Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
    Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
    Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
    Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.